Literature DB >> 33549131

Oxygen administration for patients with ARDS.

Shinichiro Ohshimo1.   

Abstract

Acute respiratory distress syndrome (ARDS) is a fatal condition with insufficiently clarified etiology. Supportive care for severe hypoxemia remains the mainstay of essential interventions for ARDS. In recent years, adequate ventilation to prevent ventilator-induced lung injury (VILI) and patient self-inflicted lung injury (P-SILI) as well as lung-protective mechanical ventilation has an increasing attention in ARDS.Ventilation-perfusion mismatch may augment severe hypoxemia and inspiratory drive and consequently induce P-SILI. Respiratory drive and effort must also be carefully monitored to prevent P-SILI. Airway occlusion pressure (P0.1) and airway pressure deflection during an end-expiratory airway occlusion (Pocc) could be easy indicators to evaluate the respiratory drive and effort. Patient-ventilator dyssynchrony is a time mismatching between patient's effort and ventilator drive. Although it is frequently unrecognized, dyssynchrony can be associated with poor clinical outcomes. Dyssynchrony includes trigger asynchrony, cycling asynchrony, and flow delivery mismatch. Ventilator-induced diaphragm dysfunction (VIDD) is a form of iatrogenic injury from inadequate use of mechanical ventilation. Excessive spontaneous breathing can lead to P-SILI, while excessive rest can lead to VIDD. Optimal balance between these two manifestations is probably associated with the etiology and severity of the underlying pulmonary disease.High-flow nasal cannula (HFNC) and non-invasive positive pressure ventilation (NPPV) are non-invasive techniques for supporting hypoxemia. While they are beneficial as respiratory supports in mild ARDS, there can be a risk of delaying needed intubation. Mechanical ventilation and ECMO are applied for more severe ARDS. However, as with HFNC/NPPV, inappropriate assessment of breathing workload potentially has a risk of delaying the timing of shifting from ventilator to ECMO. Various methods of oxygen administration in ARDS are important. However, it is also important to evaluate whether they adequately reduce the breathing workload and help to improve ARDS.

Entities:  

Keywords:  Acute respiratory failure; Complication; Extracorporeal membrane oxygenation; High-flow nasal cannula; Mechanical ventilation; Non-invasive positive pressure ventilation; Prognosis

Year:  2021        PMID: 33549131     DOI: 10.1186/s40560-021-00532-0

Source DB:  PubMed          Journal:  J Intensive Care        ISSN: 2052-0492


  61 in total

1.  Acute respiratory distress syndrome: the Berlin Definition.

Authors:  V Marco Ranieri; Gordon D Rubenfeld; B Taylor Thompson; Niall D Ferguson; Ellen Caldwell; Eddy Fan; Luigi Camporota; Arthur S Slutsky
Journal:  JAMA       Date:  2012-06-20       Impact factor: 56.272

Review 2.  Mortality rates for patients with acute lung injury/ARDS have decreased over time.

Authors:  Massimo Zambon; Jean-Louis Vincent
Journal:  Chest       Date:  2008-02-08       Impact factor: 9.410

3.  The airway occlusion pressure (P0.1) to monitor respiratory drive during mechanical ventilation: increasing awareness of a not-so-new problem.

Authors:  Irene Telias; Felipe Damiani; Laurent Brochard
Journal:  Intensive Care Med       Date:  2018-01-19       Impact factor: 17.440

4.  Airway Occlusion Pressure As an Estimate of Respiratory Drive and Inspiratory Effort during Assisted Ventilation.

Authors:  Irene Telias; Detajin Junhasavasdikul; Nuttapol Rittayamai; Lise Piquilloud; Lu Chen; Niall D Ferguson; Ewan C Goligher; Laurent Brochard
Journal:  Am J Respir Crit Care Med       Date:  2020-05-01       Impact factor: 21.405

5.  Acute respiratory distress in adults.

Authors:  D G Ashbaugh; D B Bigelow; T L Petty; B E Levine
Journal:  Lancet       Date:  1967-08-12       Impact factor: 79.321

6.  Recent trends in acute lung injury mortality: 1996-2005.

Authors:  Sara E Erickson; Greg S Martin; J Lucian Davis; Michael A Matthay; Mark D Eisner
Journal:  Crit Care Med       Date:  2009-05       Impact factor: 7.598

7.  The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material.

Authors:  Niall D Ferguson; Eddy Fan; Luigi Camporota; Massimo Antonelli; Antonio Anzueto; Richard Beale; Laurent Brochard; Roy Brower; Andrés Esteban; Luciano Gattinoni; Andrew Rhodes; Arthur S Slutsky; Jean-Louis Vincent; Gordon D Rubenfeld; B Taylor Thompson; V Marco Ranieri
Journal:  Intensive Care Med       Date:  2012-08-25       Impact factor: 17.440

Review 8.  Monitoring Patient Respiratory Effort During Mechanical Ventilation: Lung and Diaphragm-Protective Ventilation.

Authors:  Michele Bertoni; Savino Spadaro; Ewan C Goligher
Journal:  Crit Care       Date:  2020-03-24       Impact factor: 9.097

9.  High Respiratory Drive and Excessive Respiratory Efforts Predict Relapse of Respiratory Failure in Critically Ill Patients with COVID-19.

Authors:  Pierre Esnault; Michael Cardinale; Sami Hraiech; Philippe Goutorbe; Karine Baumstrack; Eloi Prud'homme; Julien Bordes; Jean-Marie Forel; Eric Meaudre; Laurent Papazian; Christophe Guervilly
Journal:  Am J Respir Crit Care Med       Date:  2020-10-15       Impact factor: 21.405

View more
  3 in total

1.  Pheochromocytoma Crisis Presenting With ARDS Successfully Treated With ECMO-Assisted Adrenalectomy.

Authors:  Manita Choudhary; Yufei Chen; Oren Friedman; Natasha Cuk; Anat Ben-Shlomo
Journal:  AACE Clin Case Rep       Date:  2021-03-26

2.  Association between SpO2/FiO2 Ratio and PaO2/FiO2 Ratio in Different Modes of Oxygen Supplementation.

Authors:  Sheetal Babu; Kundavaram Pp Abhilash; Subramani Kandasamy; Mahasampath Gowri
Journal:  Indian J Crit Care Med       Date:  2021-09

3.  Comparison of Circular and Parallel-Plated Membrane Lungs for Extracorporeal Carbon Dioxide Elimination.

Authors:  Leonie S Schwärzel; Anna M Jungmann; Nicole Schmoll; Stefan Caspari; Frederik Seiler; Ralf M Muellenbach; Moritz Bewarder; Quoc Thai Dinh; Robert Bals; Philipp M Lepper; Albert J Omlor
Journal:  Membranes (Basel)       Date:  2021-05-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.